Pharmacogenetics in the Treatment of Cardiovascular Diseases and Its Current Progress Regarding Implementation in the Clinical Routine Dávila Fajardo, Cristina Lucía Díaz Villamarín, Xando Antúnez Rodríguez, Alba Fernández Gómez, Ana Estefanía García Navas, Paloma Martínez González, Luis Javier Dávila Fajardo, José Augusto Cabeza-Barrera, José pharmacogenetics clopidogrel warfarin There is a special interest in the implementation of pharmacogenetics in clinical practice, although there are some barriers that are preventing this integration. A large part of these pharmacogenetic tests are focused on drugs used in oncology and psychiatry fields and for antiviral drugs. However, the scientific evidence is also high for other drugs used in other medical areas, for example, in cardiology. In this article, we discuss the evidence and guidelines currently available on pharmacogenetics for clopidogrel, warfarin, acenocoumarol, and simvastatin and its implementation in daily clinical practice. 2024-12-12T12:45:06Z 2024-12-12T12:45:06Z 2019-04-01 journal article Dávila Fajardo, C.L. et. al. Genes 2019, 10(4), 261. [https://doi.org/10.3390/genes10040261] https://hdl.handle.net/10481/97957 10.3390/genes10040261 eng http://creativecommons.org/licenses/by/4.0/ open access Atribución 4.0 Internacional MDPI